Martin S. Tallman has joined Memorial Sloan Kettering as Chief of the Leukemia Service.
Martin S. Tallman has joined Memorial Sloan Kettering as Chief of the Leukemia Service within the Division of Hematologic Oncology in the Department of Medicine. Dr. Tallman is an internationally recognized expert in the treatment of both acute and chronic leukemias, and the development of new therapies for these cancers. A noted clinical researcher, he has led a number of important clinical trials that have established new standards of care for leukemia patients.
Before joining Memorial Sloan Kettering, Dr. Tallman spent more than 20 years at Northwestern University where he was Co-Director of the Hematologic Malignancy Program at the Robert H. Lurie Comprehensive Cancer Center and Associate Chief of the Division of Hematology/Oncology at the Feinberg School of Medicine of Northwestern University. He received his medical degree from Chicago Medical School, did his residency at Northwestern, and completed a fellowship at the Fred Hutchinson Cancer Research Center and the University of Washington. Dr. Tallman is board certified in internal medicine, hematology, and medical oncology.